Related Experiment Video

Updated: Sep 27, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K

Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers

Xin Chen1, Yi Liu1, Hejing Liu1

  • 1Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.

Pharmacology & Therapeutics
|April 14, 2022
PubMed

Insights

Human papillomavirus (HPV)-negative cancers have poor prognoses. Noncoding RNAs (ncRNAs) are key regulators in these tumors, offering potential therapeutic targets for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Human papillomavirus (HPV)-negative tumors present significant clinical challenges due to high metastasis rates and diagnostic difficulties.
  • These cancers are associated with poorer patient prognoses and higher mortality compared to HPV-positive cancers.
  • Noncoding RNAs (ncRNAs) are increasingly recognized for their regulatory roles in physiological processes and disease, including cancer development.

Purpose of the Study:

  • To review the role of ncRNAs in the pathogenesis of HPV-negative tumors.
  • To explore how ncRNAs regulate gene expression and signal transduction in HPV-negative cancers.
  • To identify ncRNAs as potential biomarkers and therapeutic targets for HPV-negative cancers.

Main Methods:

  • Literature review of studies investigating ncRNAs in HPV-negative cancers.
  • Analysis of ncRNA functions in regulating tumor development and progression.
  • Examination of ncRNA interactions with target molecules in cancer pathways.

Main Results:

  • Dysregulated ncRNAs are implicated in the occurrence and progression of HPV-negative tumors.
  • ncRNAs influence HPV-negative cancer development by modulating gene expression and signaling pathways.
  • ncRNAs act on target molecules, directly or indirectly, to affect tumor behavior.

Conclusions:

  • ncRNAs play a critical role in the development and progression of HPV-negative cancers.
  • Understanding ncRNA functions is essential for identifying biomarkers and developing novel therapeutic strategies.
  • Targeting ncRNAs presents a promising avenue for future precision therapy in HPV-negative cancers.
Keywords:
CarcinogenesisHPV-negative cancerLncRNAsNoncoding RNAmiRNAs

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K
In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

15.9K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
177
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K